Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)
|更新时间:2024-12-17
|
Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)
“Based on the RIGHT list framework, the research team of Zhejiang University of Traditional Chinese Medicine has developed the traditional Chinese patent medicines and simple preparations clinical application practice guide report specification, improved the quality and transparency of traditional Chinese patent medicines and simple preparations guide report, and promoted clinical rational application.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 1, Pages: 211-218(2025)
王憭瑶,潘赫婧,张乐等.中成药临床应用实践指南的报告规范(RIGHT for CPM)解读[J].中国实验方剂学杂志,2025,31(01):211-218.
WANG Liaoyao,PAN Hejing,ZHANG Le,et al.Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(01):211-218.
WANG Liaoyao,PAN Hejing,ZHANG Le,et al.Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(01):211-218. DOI: 10.13422/j.cnki.syfjx.20241126.
Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)
Interpretation of Chinese Expert Consensus on Integrated Chinese and Western Medicine Management of Wilson Disease-related Renal Damage
Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease
Clinical Comprehensive Evaluation of Chinese Patent Medicines in Treatment of Stable Angina Pectoris with Qi Stagnation and Blood Stasis
GRADE Clinical Study Evidence Evaluation and Expert Consensus on Antihypertensive Chinese Patent Medicines Combined with Western Medicines for Treatment of Hypertension
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Related Author
YANG Wenming
DIAO Ke
XI Hu
RAO Zhihong
WEI Taohua
YANG Yulong
FANG Shuzhen
CHEN Jiaping
Related Institution
Wangjing Hospital,China Academy of Chinese Medical Sciences
National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences
Institute of Xin'an Medicine and Modernization of Traditional Chinese Medicine,Hefei Comprehensive National Science Center
Key Laboratory of Xin'an Medicine,Ministry of Education
The First Affiliated Hospital of Anhui University of Chinese Medicine